Both Innovaderma and Versarien are (or were) popular retail stocks in the past. Both of them have similarities in the fact that both share prices have been much, much higher, and both of them have had marmite directors at the helm. The similarities stop there. One produces graphene, and one does not. One makes a profit, and the other does not.
Innovaderma
Innovaderma is a business that does a bit of everything, with its popular brand Skinny Tan (which my wife tells me is a terrible product) and a device called Prolong that claims to be “the world’s only FDA-cleared medical device for premature ejaculation” (a product I have not tried).
In recent months, it has seen the decks cleared with unpopular Executive Chairman Haris Chaudry leaving and selling his entire shareholding, and a positive trading statement. I already hold a long position in this stock, and the price action could now be looking a lot more bullish if it makes a move above the 200 MA.
We can see that the price has been steadily in a downtrend from at least September 2018, and the price has now managed to break that trendline.
Disclaimer: Please note all prices are for information only, they should not be relied upon for accuracy or trading. All prices quotes are based on CFD prices and are similar though not always identical to real exchange prices. STOCKTRKR or anybody connected with STOCKTRKR will not accept any liability for loss or damage arising from use of any information/commentary/charts or articles which is provided 'as is' for educational purposes only, nothing contained on this website should be considered as investment advice - please seek proper investment advice from registered financial broker or institution if you wish to trade on global markets and ensure you are familiar with the risks.
